Register entry
- Registered sites
- 0
- Active NDC listings
- 20
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
2020 active NDC listings: 20 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 20.
| Dosage form | NDCs |
|---|---|
| injection, solution | 17 |
| injection, suspension | 3 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| eli lilly italia spa | 20 |
Catalogue
Marketed products
20| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Dulaglutide | injection, solution | 54568-001DRUG FOR FURTHER PROCESSING |
| - | Dulaglutide | injection, solution | 54568-003DRUG FOR FURTHER PROCESSING |
| - | Dulaglutide | injection, solution | 54568-004DRUG FOR FURTHER PROCESSING |
| - | Insulin glargine | injection, solution | 54568-766DRUG FOR FURTHER PROCESSING |
| - | Insulin human | injection, suspension | 54568-319DRUG FOR FURTHER PROCESSING |
| - | Insulin human | injection, suspension | 54568-719DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | injection, suspension | 54568-739DRUG FOR FURTHER PROCESSING |
| - | Insulin lispro | injection, solution | 54568-751DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-043DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-170DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-325DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-341DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-342DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-343DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-344DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-345DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-346DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-460DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-471DRUG FOR FURTHER PROCESSING |
| - | tirzepatide | injection, solution | 54568-837DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing tirzepatide
- Eli Lilly and Company10 sites · 189 NDC
- International Medication Systems, Ltd.3 sites · 2,801 NDC
- BSP Pharmaceuticals SpA1 site · 40 NDC
- Resilience US, LLC1 site · 18 NDC
- Chengdu Shengnuo Biopharm Co., Ltd.1 site · 15 NDC
- Suzhou Lixin Pharmaceutical Co., Ltd.1 site · 5 NDC
- Zhejiang Kingland Pharmaceutical Company Limited0 sites · 4 NDC
Enquiry
Common questions
- Is Eli Lilly Italia SPA FDA approved?
- Eli Lilly Italia SPA holds no registered establishment of its own; 20 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Eli Lilly Italia SPA make?
- 20 products are listed under Eli Lilly Italia SPA in the openFDA NDC Directory, most often as injection, solution; injection, suspension. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.